Blumhouse and Atomic Monster Productions Surpass $1 Billion in 2025 Global Box Office

Blumhouse and Atomic Monster have exceeded $1 billion in combined worldwide box office earnings for 2025. The milestone marks the first time the merged companies achieve this threshold in a single calendar year. Eight productions contributed to the total of $1.022 billion. Horror titles dominated the slate under the leadership of Jason Blum and James Wan.

‘The Conjuring: Last Rites’ led the lineup with $494.6 million globally. The film represents the highest-grossing entry in the franchise, surpassing ‘The Nun’s’ $366 million in 2018. It stands as the only installment to cross $400 million worldwide. Patrick Wilson and Vera Farmiga reprised their roles in the R-rated feature directed by Michael Chaves.

This performance accounts for 48 percent of the year’s combined haul. Additional releases bolstered the aggregate through varied theatrical runs. The companies merged operations following Wan’s Atomic Monster integration with Blumhouse. The partnership expanded output while maintaining low-budget horror models.

Blumhouse previously achieved standalone billion-dollar years prior to the merger. Atomic Monster contributed hits like ‘M3GAN’ and ‘The Nun II’ in recent cycles. The 2025 slate emphasized franchise extensions and original concepts. Analysts attribute success to consistent audience demand for genre films.

‘The Conjuring: Last Rites’ benefited from established fanbase loyalty. Marketing highlighted finality in the series narrative. International markets drove significant portions of revenue. The film secured strong openings across multiple territories.

Industry observers note horror’s resilience amid shifting theatrical trends. Low production costs yield high returns for Blumhouse productions. Atomic Monster adds technical expertise in supernatural elements. The collaboration positions the entities for continued dominance.

This billion-dollar mark aligns with broader 2025 box office recovery patterns. Domestic totals reached $8 billion earlier in the year. Global figures reflect sustained interest in event programming. Horror remains a reliable performer during uncertain periods.

Blumhouse plans further expansions into television and streaming. Atomic Monster develops additional shared universe projects. Upcoming slates include sequels and new intellectual properties. The companies maintain focus on creator-driven content.

The achievement underscores horror’s commercial viability in modern Hollywood. Franchise management proves key to sustained earnings. Blum and Wan expressed commitment to innovative scares. Future releases target similar budget-to-profit ratios.

This milestone reinforces the merged entity’s market position. Competitors monitor output for genre trends. Audience reception metrics support expanded investments. The $1 billion threshold signals robust health for specialized production houses.